vigabatrin and eye
vigabatrin has been researched along with eye in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hilton, EJ; Hosking, SL | 1 |
| Embleton, SJ; Gupta, AK; Hosking, SL; Roff Hilton, EJ | 1 |
| Ainslie, GR; Gibson, KM; Schmidt, MA; Vogel, KR; Wisor, JP | 1 |
Reviews
1 review(s) available for vigabatrin and eye
| Article | Year |
|---|---|
Neurotoxic effects of GABA-transaminase inhibitors in the treatment of epilepsy: ocular perfusion and visual performance.
Topics: 4-Aminobutyrate Transaminase; Electroretinography; Enzyme Inhibitors; Epilepsy; Eye; Humans; Regional Blood Flow; Vigabatrin; Vision Disorders | 2002 |
Trials
1 trial(s) available for vigabatrin and eye
| Article | Year |
|---|---|
Epilepsy patients treated with vigabatrin exhibit reduced ocular blood flow.
Topics: Adult; Analysis of Variance; Anticonvulsants; Blood Pressure; Cerebrovascular Circulation; Cohort Studies; Epilepsy; Eye; Female; Humans; Intraocular Pressure; Male; Middle Aged; Regional Blood Flow; Vigabatrin | 2003 |
Other Studies
1 other study(ies) available for vigabatrin and eye
| Article | Year |
|---|---|
mTOR Inhibition Mitigates Molecular and Biochemical Alterations of Vigabatrin-Induced Visual Field Toxicity in Mice.
Topics: Animals; Cell Line; Enzyme Inhibitors; Evoked Potentials, Visual; Eye; Humans; Mice, Inbred C57BL; Monomeric GTP-Binding Proteins; Protective Agents; Receptors, GABA; Retinal Pigment Epithelium; TOR Serine-Threonine Kinases; Vigabatrin; Visual Fields | 2017 |